FDA
- Status: approved
🇺🇸 Peridural in United States
2 US adverse-event reports
Marketing authorisation
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 27 March 2025 – 27 March 2026
- Total reports: 2
Most-reported reactions
- Injection Site Thrombosis — 1 report (50%)
- Thrombophlebitis Superficial — 1 report (50%)
Other Other approved in United States
Frequently asked questions
Is Peridural approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Peridural in United States?
Iuliu Hatieganu University of Medicine and Pharmacy is the originator. The local marketing authorisation holder may differ — check the official source linked above.